NVDA gained a massive 197% since our AI first added it in November - is it time to sell? 🤔Read more

Atlassian Gave Cautious Q2 Outlook Amid Uncertain Macro Environment, Analysts Cut Price Targets

Published 04/11/2022, 16:00
Updated 04/11/2022, 17:10
© Reuters.  Atlassian Gave Cautious Q2 Outlook Amid Uncertain Macro Environment, Analysts Cut Price Targets
TGTB34
-
TEAM
-
ASTB
-

  • Atlassian Corp (NASDAQ: TEAM) reported first-quarter revenue growth of 31% year-on-year to $807.4 million, beating the consensus of $806.4 million. Subscription revenue rose 50% Y/Y to $651 million.
  • Non-GAAP operating margin was 18%.
  • EPS of $0.36 missed the consensus of $0.38.
  • Scott Farquhar, Atlassian's co-founder and co-CEO, said, "Despite the turbulent macroeconomic environment we find ourselves in, we have conviction about the incredible long-term opportunities in front of us and our ability to capitalize on them."
  • "We have the right products, the right leaders, and the right strategies in place to come out of this downturn in a much stronger market position."
  • Atlassian sees Q2 revenue of $835 million - $855 million, below the consensus of $879.2 million.
  • It sees a non-GAAP operating margin of 13%.
  • Piper Sandler analyst James Fish downgraded Atlassian from Overweight to Neutral.
  • Mizuho analyst Gregg Moskowitz maintained a Buy and cut the price target from $320 to $255.
  • Goldman Sachs (NYSE:GS) analyst Kash Rangan maintained a Buy and cut the price target from $300 to $265.
  • Macquarie analyst Frederick Havemeyer downgraded from Outperform to Neutral and lowered the price target from $287 to $147.
  • BMO Capital analyst Keith Bachman maintained a Market Perform and lowered the price target from $295 to $160.
  • Price Action: TEAM shares traded lower by 28.4% at $124.80 on the last check Friday.
Latest Ratings for TEAM DateFirmActionFromTo
Jan 2022Cowen & Co.MaintainsMarket Perform
Jan 2022Cowen & Co.MaintainsMarket Perform
Dec 2021Goldman SachsInitiates Coverage OnNeutral
View More Analyst Ratings for TEAM

View the Latest Analyst Ratings

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.